Curasight to develop its proprietary uTRACE® PET imaging technology to obtain regulatory approval in EU and USA, with Curium responsible for manufacturing and commercialization Curasight eligible for up to USD 70 mn in development and commercial milestones as well as double-digit royalties on sales on eventual commercialization The agreement supports Curasight’s strategy to leverage partnerships as it […]
Abstract submissions are now being accepted for the 46th World Hospital Congress, which takes place from 25 to 27 October 2023 in Lisbon, Portugal.
Cleveland Clinic and IBM recently unveiled the first quantum computer in the world to be uniquely dedicated to healthcare research with an aim to help accelerate biomedical discoveries.
Fresenius Kabi, a global health care company that specializes in medicines and technologies for infusion, transfusion, and clinical nutrition, announced that its Ivenix Infusion System has received an Innovative Technology contract from Vizient, the United States’ largest member-driven healthcare performance improvement company. Vizient members include more than half of all acute care hospitals in the […]
Owen Mumford has been awarded a prestigious Red Dot award for its Aidaptus single-use auto-injector launched in 2021. Aidaptus wins the Red Dot award for the category Product Design 2023.
Orion Health has appointed Mark Hindle as its new vice president for the UK and Ireland. Mark has joined the leading supplier of digital tools to improve healthcare experience from Evergreen Life, a personal health record app provider.
Digital clinical diagnostics and diabetes home testing provider Digostics and University Hospital Southampton NHS Foundation Trust (UHS) have established a partnership that will see expectant mothers under the care of UHS maternity services become the first, anywhere in the world, to access new, ground-breaking remote testing technology designed to improve screening for gestational diabetes mellitus […]
Santa Clara, California-based Proxim Diagnostics, a company developing a handheld, point-of care diagnostic device, has received a strategic investment from bioMérieux, a world leader in the field of in vitro diagnostics.
SolasCure, a biotechnology company developing a hydrogel containing a recombinant enzyme derived from maggots which aims to accelerate wound debridement, has announced the completion of its £10.9m (about US$13.3m) Series B investment round.
Robert (Bobbie) Dressen, CEO of Medical Alley, and Brigit van Dijk – van de Reijt, CEO of the Brabant Development Agency (BOM), on behalf of ROM NL, signed a Memorandum of Understanding (MOU) in the presence of Minister Kuipers of Health, Welfare and Sport.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
